|
🐜
|
Tenascin-C drives persistence of organ fibrosis
15 auth.
S. Bhattacharyya,
Wenxia Wang,
Luisa Morales-Nebreda,
G. Feng,
Minghua Wu,
Xiaodong Zhou,
R. Lafyatis,
J. Lee,
M. Hinchcliff,
C. Feghali-Bostwick,
...
K. Lakota,
G. R. Budinger,
Kirtee Raparia,
Z. Tamaki,
J. Varga
|
7 |
2016 |
7
🐜
|
|
🐜
|
Rapid On-Site Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspirations for the Diagnosis of Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society.
20 auth.
D. Jain,
T. Allen,
D. Aisner,
M. Beasley,
P. Cagle,
V. Capelozzi,
L. Hariri,
S. Lantuejoul,
R. Miller,
M. Mino‐Kenudson,
...
S. Monaco,
A. Moreira,
Kirtee Raparia,
N. Rekhtman,
A. Roden,
S. Roy-Chowdhuri,
G. da Cunha Santos,
E. Thunnissen,
G. Troncone,
M. Vivero
|
7 |
2017 |
7
🐜
|
|
🐜
|
Programmed Death Ligand-1 Immunohistochemistry--A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology Society.
18 auth.
L. Sholl,
D. Aisner,
T. Allen,
M. Beasley,
A. Borczuk,
P. Cagle,
V. Capelozzi,
S. Dacic,
L. Hariri,
K. Kerr,
...
S. Lantuejoul,
M. Mino‐Kenudson,
Kirtee Raparia,
N. Rekhtman,
S. Roy-Chowdhuri,
E. Thunnissen,
M. Tsao,
Y. Yatabe
|
6 |
2016 |
6
🐜
|
|
🐜
|
Biomarkers for PD-1/PD-L1 Blockade Therapy in Non-Small-cell Lung Cancer: Is PD-L1 Expression a Good Marker for Patient Selection?
7 auth.
Y. Chae,
Alan Pan,
A. Davis,
Kirtee Raparia,
N. Mohindra,
M. Matsangou,
...
F. Giles
|
6 |
2016 |
6
🐜
|
|
🐜
|
Primary Pulmonary Lymphoid Lesions: Radiologic and Pathologic Findings.
7 auth.
Arlene Sirajuddin,
Kirtee Raparia,
V. A. Lewis,
T. Franks,
S. Dhand,
J. Galvin,
...
Charles S. White
|
6 |
2016 |
6
🐜
|
|
🐜
|
Biomarker Testing in Lung Carcinoma Cytology Specimens: A Perspective From Members of the Pulmonary Pathology Society.
21 auth.
S. Roy-Chowdhuri,
D. Aisner,
T. Allen,
M. Beasley,
A. Borczuk,
P. Cagle,
V. Capelozzi,
S. Dacic,
G. da Cunha Santos,
L. Hariri,
...
K. Kerr,
S. Lantuejoul,
M. Mino‐Kenudson,
A. Moreira,
Kirtee Raparia,
N. Rekhtman,
L. Sholl,
E. Thunnissen,
M. Tsao,
M. Vivero,
Y. Yatabe
|
6 |
2016 |
6
🐜
|
|
🐜
|
Association of Tumor Mutational Burden With DNA Repair Mutations and Response to Anti–PD‐1/PD‐L1 Therapy in Non–Small‐Cell Lung Cancer
8 auth.
Y. Chae,
A. Davis,
Kirtee Raparia,
Sarita Agte,
Alan Pan,
N. Mohindra,
...
V. Villaflor,
F. Giles
|
6 |
2019 |
6
🐜
|
|
🐜
|
SIRT3 is attenuated in systemic sclerosis skin and lungs, and its pharmacologic activation mitigates organ fibrosis
10 auth.
K. Akamata,
Jun Wei,
Mitra Bhattacharyya,
P. Cheresh,
M. Bonner,
J. Arbiser,
...
Kirtee Raparia,
Mahesh P. Gupta,
D. Kamp,
J. Varga
|
6 |
2016 |
6
🐜
|
|
🐜
|
TLR4-dependent fibroblast activation drives persistent organ fibrosis in skin and lung.
13 auth.
S. Bhattacharyya,
Wenxia Wang,
W. Qin,
K. Cheng,
Sara K Coulup,
Sherry A Chavez,
Shuangshang Jiang,
Kirtee Raparia,
Lúcia de Almeida,
C. Stehlik,
...
Z. Tamaki,
H. Yin,
J. Varga
|
6 |
2018 |
6
🐜
|
|
🦁
|
Clinical outcomes for "suspicious" category in thyroid fine-needle aspiration biopsy: Patient's sex and nodule size are possible predictors of malignancy.
Kirtee Raparia,
S. Min,
D. Mody,
R. Anton,
M. Amrikachi
|
6 |
2009 |
6
🦁
|
